Blood Advances
Overview
Blood Advances is a peer-reviewed medical journal that focuses on the latest advancements in hematology. It publishes cutting-edge research and clinical studies related to blood disorders, transfusion medicine, and hematologic malignancies. With a multidisciplinary approach, the journal provides valuable insights into the diagnosis, treatment, and management of various blood-related conditions, making it an essential resource for hematologists, oncologists, and researchers in the field.
Details
Details
Abbr.
Blood Adv
Start
2016
End
Continuing
Frequency
Semimonthly
p-ISSN
2473-9529
e-ISSN
2473-9537
Country
United States
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 4009
85
SJR / Ranks: 575
3065
CiteScore / Ranks: 1055
11.50
JIF / Ranks: 763
7.5
Recent Articles
1.
Banerjee R, Richards A, Midha S, Afrough A, Anwer F, Atanackovic D, et al.
Blood Adv
. 2025 Mar;
PMID: 40088469
No abstract available.
2.
3.
Trneny M, Fogliato L, Gardner F, Flinn I, Larouche J, Haioun C, et al.
Blood Adv
. 2025 Mar;
PMID: 40088467
No abstract available.
4.
Trebak F, Sako M, Grover S, Seanoon K, Pawlinski I, Moonla C, et al.
Blood Adv
. 2025 Mar;
PMID: 40086080
Sickle cell trait (SCT) is present in subjects who possess a single copy of the bS-globin gene mutation. While most affected individuals are asymptomatic, SCT is a well-established risk factor...
5.
Prabahran A, Wu L, Manley A, Wu Z, Gao S, Mizumaki H, et al.
Blood Adv
. 2025 Mar;
PMID: 40086077
Megakaryocytes (MKs) serve diverse roles beyond platelet production, including hematopoietic stem cell maintenance and immune response modulation. In our mouse model of immune bone marrow failure (BMF), we observed the...
6.
Huntington J, Reckless J, Polderdijk S, Hextall P, Baglin T
Blood Adv
. 2025 Mar;
PMID: 40086076
The concept of restoring hemostasis by down-tuning anticoagulant pathways holds the promise of treating all forms of hemophilia. Here we report preclinical efficacy and safety data for SerpinPC, a covalent...
7.
Iding A, Ten Cate V, Ten Cate H, Wild P, Ten Cate-Hoek A
Blood Adv
. 2025 Mar;
PMID: 40086064
Post-thrombotic syndrome (PTS) is a heterogenous chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to...
8.
Nagayama T, Fujiwara S, Nishiwaki S, Wada F, Uchida N, Tanaka M, et al.
Blood Adv
. 2025 Mar;
PMID: 40085961
Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-matched donors is the gold standard. However, haploidentical stem cell transplantation using posttransplant cyclophosphamide (PTCY-haplo) and cord blood transplants (CBTs) are alternatives when...
9.
Argueta D, Avalos B, Goel Y, Tran H, Fotio Y, Piomelli D, et al.
Blood Adv
. 2025 Mar;
PMID: 40085960
Chronic and acute pain are major comorbidities of sickle cell disease (SCD). Both peripheral and central nervous system mechanisms underlie SCD pain. We investigated the potential roles of endogenous fatty...
10.
Baranwal A, Langer K, Gannamani V, Rud D, Cibich A, Saygin C, et al.
Blood Adv
. 2025 Mar;
PMID: 40085959
Allogeneic stem cell transplant (alloHCT) is considered for all patients with myeloid neoplasms (MN) harboring TP53-mutations (TP53mut). The aim of this international study across 7 transplant centers in USA and...